Considering the results from metabolomics and genomics, we speculated that the taurine metabolic pathway might be mechanistically involved in Nmnat1-LKO–deteriorated hepatic steatosis in ALD. The gene discussed is NMNAT1; the disease is Hepatic steatosis.